-
We expect Indian pharma companies to generate strong revenues from the US generic market due to the receipt of many ANDA approvals from US FDA
We expect Indian pharma companies to generate strong revenues from…
Read more -
Cadila, Torrent surge Ahead for Merger
MUMBAI: Even as the shares of Indian pharmaceutical companies are…
Read more -
India needs to revisit its bilateral investment treaties programme to ensure that multilateral gains on patents are not lost
India needs to revisit its bilateral investment treaties programme to…
Read more -
-
Politicians have mismanaged Indian economy for the last 50 years: Marc Faber
NEW DELHI: India has pursued poor economic policies and the…
Read more -
Global Economic Mess & Policy Paralysis in Indian Pharma Sector result sluggish growth, Sales & Profits decline!
The revenue growth and profit margins of leading 50 pharmaceutical…
Read more -
-
Flouting ethics in Clinical Trials
Committee questions roles of ICMR, Drug Controller in the “intriguing”…
Read more -
The currency problem perhaps has its roots partially in the high current account deficit and partially in the likelihood of tapering of the QE by the US
We may see the market bottom within 3 months Amid…
Read more -
Ajanta Pharma in ‘Forbes Asia’s 200 Best under a Billion’ list
Ajanta Pharma, a Rs.900 crore plus specialty focused pharmaceutical formulation company…
Read more